University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 2 of 27
Clinician Satisfaction With the VERABAND™
NCT06080464
Hemodynamics After Resistance Training
NCT07022340
Emotional Awareness and Expression Therapy for Chronic Pain and Opioid Use Disorder
NCT06865560
Implant Phenotype Modification Via GBR and ADM
NCT07082244
ADAPT Micro-Randomized Trial
NCT06915220
Training Community Members to be Coaches to Deliver the HealthyLifetime Program
NCT06616246
Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk
NCT06941311
Characterization and Analysis of Evoked Cortical Responses in Participants With Medication-intractable Epilepsy
NCT07014592
Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program
NCT06784895
Outpatient VR (Virtual Reality)-Brain-gut Behavioral Therapies (BGBT) in Inflammatory Bowel Disease (IBD)
NCT06910787
Family Acceptance Project Online (Pilot RCT)
NCT06839859
Patient-Centered Decision Support for Eosinophilic Esophagitis
NCT06817213
Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis
NCT06880627
Vancomycin Dose Optimization in Obesity
NCT06601257
De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
NCT06934564
Families in Balance: Enhancing Household Routines and Reducing Early Childhood Obesity Among Families With Low-income
NCT06795490
Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia
NCT06840470
Brief Pain Reprocessing Therapy in Veterans
NCT06771713
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients
NCT06677151
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
NCT06785116
Precision Antibiotic Dosing for Appendectomy
NCT06860802
Multifocal HD-tDCS and Motor Function
NCT06561165
Regenerative Peripheral Nerve Interface for Control of Lower Limb Prostheses
NCT06275282
Promotion of Exercise Through Physical Therapy for Multiple Sclerosis: A Pilot Study
NCT06933160
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
NCT06574035
Optimizing Low Vision Rehabilitation in Emotionally Distressed Patients With Inherited Retinal Diseases
NCT06651736
Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial
NCT06671002
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
NCT06563310
Adversity, Brain and Opioid Use Study
NCT06355778
Empower@Home: Community Implementation for Older Adults With Ambulatory Disabilities
NCT06721559
Bioresorbable Airway Splint Pivotal Clinical Trial
NCT06406452
Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing
NCT06629272
Move and Snooze: Adding Insomnia Treatment to an Exercise Program to Improve Pain Outcomes in Older Adults With Knee Osteoarthritis
NCT06580561
Impact of Therapy Dogs on Child Anxiety and Behavior During Local Anesthesia for Dental Procedures
NCT06725134
Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction
NCT06529679
Community Based Treatment for (ComBaT) Glaucoma
NCT06124521
Empower@Home: Hybrid Effectiveness-Implementation Randomized Controlled Trial (RCT)
NCT06584422
TENS in Scleroderma
NCT06646913
Fibromyalgia Sleep A to ZZZ Study
NCT06567886
Efficacy-Implementation Study for PC CARES in Rural Alaska
NCT06658808
Using Consumer-grade Wearable Devices for Fall Risk Evaluation and Alerts
NCT06508892
Ultrasound for Socket Healing Evaluation
NCT06017193
A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
NCT06430528
Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children
NCT06587529
Cryoablation Effects on Acute and Chronic Pain After Thoracotomy and Thoracoscopy
NCT06384664
Multimodal Investigation of Neural Plasticity
NCT06453980
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
NCT06195605
Enhancing Purpose and Well-Being Through a Volunteering Experience Connecting Veterans With English Language Learners
NCT06324383
M-Well Bonding Bundle to Improve Patient-Physician Relationships
NCT06354920
MIVetsCan: Can-Coach Trial (Phase 2)
NCT06283862
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Michigan pipeline card: 1,327 registered trials from official public datasets.Report a data error.